HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helicobacter pyloril-asparaginase: a promising chemotherapeutic agent.

Abstract
Bacterial L-asparaginases are amidohydrolases that catalyse the conversion of L-asparagine to L-aspartate and ammonia and are used as anti-cancer drugs. The current members of this class of drugs have several toxic side effects mainly due to their associated glutaminase activity. In the present study, we report the molecular cloning, biochemical characterisation and in vitro cytotoxicity of a novel L-asparaginase from the pathogenic strain Helicobacter pylori CCUG 17874. The recombinant enzyme showed a strong preference for L-asparagine over L-glutamine and, in contrast to most L-asparaginases, it exhibited a sigmoidal behaviour towards L-glutamine. The enzyme preserved full activity after 2 h incubation at 45 degrees C. In vitro cytotoxicity assays revealed that different cell lines displayed a variable sensitivity towards the enzyme, AGS and MKN28 gastric epithelial cells being the most affected. These findings may be relevant both for the interpretation of the mechanisms underlying H. pylori associated diseases and for biomedical applications.
AuthorsDonata Cappelletti, Laurent R Chiarelli, Maria Valentina Pasquetto, Simona Stivala, Giovanna Valentini, Claudia Scotti
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 377 Issue 4 Pg. 1222-6 (Dec 26 2008) ISSN: 1090-2104 [Electronic] United States
PMID18983825 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Bacterial Proteins
  • Asparaginase
Topics
  • Antineoplastic Agents (chemistry, pharmacology)
  • Asparaginase (chemistry, genetics, pharmacology)
  • Bacterial Proteins (chemistry, genetics, pharmacology)
  • Cell Line, Tumor
  • Cloning, Molecular
  • Enzyme Stability
  • Helicobacter pylori (enzymology, genetics)
  • Humans
  • Hydrogen-Ion Concentration
  • Inhibitory Concentration 50
  • Models, Molecular

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: